ERBB2 and breast carcinoma: Complex 13, for example, typically showed high binding affinity (−71.1 kcal/mol) to HER2, collaborating the high in vitro activity against prostate, colon and breast cancer cell lines (IC50 = 0.03, 0.25, and 0.07 μM respectively) reported by our group.